THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD. PROVIDES SHAREHOLDER UPDATE AND ANNOUNCES $10 MILLION NON-BROKERED FINANCING

Size: px
Start display at page:

Download "THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD. PROVIDES SHAREHOLDER UPDATE AND ANNOUNCES $10 MILLION NON-BROKERED FINANCING"

Transcription

1 THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD. PROVIDES SHAREHOLDER UPDATE AND ANNOUNCES $10 MILLION NON-BROKERED FINANCING Dear Shareholders, It is with great pleasure that I address you today as shareholders of our company, The Green Organic Dutchman Holdings Ltd. ( TGOD ). Our Company has recently made major developments that I would like to report on. Additionally, I would like to announce a new financing. Firstly, I would like to thank all of you who participated in our last financing, which I m pleased to report was oversubscribed by 300%, allowing us to close on $13,200,000 with over 1,300 new shareholders. Please always remember that we are a shareholder driven company, managed and directed by our shareholders. UPDATE HIGHLIGHTS The Company successfully completed a heavily over-subscribed $13,200,000 initial financing. TGOD has secured an additional and contiguous 75-acre property bringing the incumbent land package to 100 acres. The company Company has added significantly to both the corporate, operational and project management teams. Engineering and design for Phase 1 Expansion of 145,000 sq. ft. commenced in January. This expansion will increase the current annual productive capacity from 1,000KG s to over 14,000KG s. Engaged Larssen Greenhouse Engineering, who specializes in the technical design and building of the most modern and sophisticated hybrid-greenhouses in the industry. Strategic Partnership formed with Eaton, one of the worlds largest power management and energy optimization companies. Strategic Partnership formed with Ledcor, one of Canadas largest construction management companies. TGOD announces its last planned financing prior to IPO.

2 PROPERTY ACQUISITION The Company secured 75-acres of contiguous land, directly adjoining the currently ACMPR licensed production facility. This additional land sets TGOD apart from much of its peers, allowing for large-scale and accelerated expansion plans. PHASE 1 EXPANSION Engineering and design for our Phase 1 expansion are well underway, and management anticipates construction to begin late in Q2, The Company has expedited its original plan and increased its size and scope, we will be executing on Phase 1, two-part expansion: Hybrid Expansion: A 125,000 sq. ft. of state-of-the-art, automated, hybrid facility Additional annual capacity of ~11,000KG s Anticipated Q initial harvest Enclosed Expansion: A 20,000 sq. ft. State of the art indoor facility Additional annual capacity of ~2,000KG s Anticipated Q initial harvest Following the completion of the Phase 1 expansion, TGOD s production capacity is expected to be ~14,000KG s annually. The Company has built a team of highly experienced power, energy optimization and construction professionals to ensure this expansion is delivered not only on-time and on-budget but also completed to the highest possible standards, potentially setting a new standard for our industry.

3 OPERATIONAL MANAGEMENT TEAM ADDITIONS (full bios can be found in presentation) Amer Cheema, M.Sc. (Hons.): Agriculture and a PhD Candidate in Post-Harvest Biology Award winning head grower with 20+ years experience in production & management of high-tech commercial greenhouses Lola Millerman, B.Sc. in Biology from UBC Senior Microbiologist and Laboratory Supervisor with Nestle Canada. Brandan Leroux, M. Sc. Candidate: Environmental & Life Science, Trent University Developed and implemented a research thesis in plant genetics with emphasis on environmental resource allocations specifically related to vegetative and sexual propagation. Chad Rigby, BSc in Environmental Biology from the University of Guelph, minor in Plant Sciences and Plant Biochemistry Previously worked with another licensed producer as production assistant. CORPORATE MANAGEMENT TEAM ADDITIONS: (full bios can be found in presentation) Jim Shone, MBA Queens, CFA Stevan Perry 20 years in the Canadian financial services industry, focused on small to medium sized enterprises. 12 years commercial banking experience (BDC for 7 years and factoring company for 4 ½ years) 20+ years as senior energy services and major projects business development executive. Successfully developed and delivered on business models and project plans for fortune 100 companies such as Honeywell and Eaton. Matt Schmidt, MBA Laurier University

4 Previously Vice President, Investment Banking at Echelon Wealth Partners - responsible for the firm s initiation into the Canadian Cannabis sector. Danny Brody 10+ years experience in finance and holds a Chartered Investment Manager (CIM) designation from the Canadian Securities Institute (CSI). Previously Director of IR at Emblem Corp. ADVISORS ADDITIONS: (full bios can be found in presentation) Brian Ast, MBA, CFA, P.Eng 20+ years experience in project bid managemnt, contract and cost control for both the public and private sector. Currently Director, Public & Private Partnerships with Honeywell Building Solutions. Harold Ruckpaul 31 years of technical, operational and sales management experience with developing and implementing power systems solutions to primary market segments on a global scale. Justin Fraser 20+ years experience in team building, including the ability to select and implement strategic relationships for optimal business performance. Currently Chairman & CEO of the Trades Labour Group. We hope that you can appreciate the amount of work that has been accomplished in such a short period (just over 60 days), and we are not going to slow down, but rather pick-up the pace now that we have rounded out our operational, management and project construction teams. To keep you informed of our developments on a regular basis Danny Brody, VP IR will be sending out a monthly update and our IR department always welcomes your calls. It is our belief that the foundation of this company is our shareholders and this is your company. As we the managing shareholders are hard at work we would like to call on all other shareholders from time to time to help grow OUR business. This is one of those times, it is imperative to our business plan that we brand the TGOD name, create awareness of our upcoming product offerings from a grass roots level (all of you) and increase the number of shareholders. So, if you think you

5 know someone that would like to learn about TGOD please take a moment and send a copy of our presentation to those interested parties. This is the best way to grow any business and remember this is your Company. In closing, we would like to announce the details of a proposed non-brokered equity financing to raise a minimum of $10,000,000. The Green Organic Dutchman Holdings Ltd. ( Company ) is pleased to announce that it is conducting a best efforts equity financing to raise aggregate gross proceeds of $10,000,000 (the Offering ) through the issuance of common share units (the "Units") at a price of $1.15 per Unit. Each Unit will consist of one common share of the Company (a "Common Share") and one common share purchase warrant of the Company (a "Warrant"). Each Warrant is exercisable into one Common Share (the "Warrant Share") at the exercise price of $2.15 per share for a period of 24 months from the closing date ( Closing Date ) of the Offering. It is intended that the Warrants will be transferable and will be subject to acceleration in the event that the volume weighted average price of the Common Shares is equal to or greater than $2.80 over a period of ten consecutive days. The Common Shares and Warrants will be subject to a six-month contractual escrow period from the date the Company s common shares (or derivative thereof) are listed on an exchange ( Listing Date ). The Warrant Shares will be subject to a twelve-month contractual escrow period from the Closing Date. "This is a unique retail shareholder driven financing, that allows as many potential patients to participate as an investor, in the upside of our Company," states Rob Anderson, CEO of TGOD. Please note that if you have an interest in the financing contact our IR department. To view a copy of the Company s full corporate presentation please visit: CONTACT INFORMATION : Investor Relations info@tgod.ca Phone: ABOUT GREEN ORGANIC DUTCHMAN The Green Organic Dutchman Ltd. Produces Farm Grown, Pharma Grade Organic Cannabis. The Company grows high quality, organically grown medical cannabis in small batches using craft growing, all natural principles. The Green Organic Dutchman Ltd. is licensed under the access to

6 cannabis for medical purposes regulations (ACMPR) to cultivate medical marijuana, and carries out its principal activities producing marijuana from its facilities in Ancaster, Ont., pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations. This update contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors -- including the availability of funds, the results of financing efforts and the parties' due diligence reviews, and general market conditions -- that could cause actual results to differ materially from the Company's expectations. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statem

TGOD THE GREEN ORGANIC DUTCHMAN SEPTEMBER, Life

TGOD THE GREEN ORGANIC DUTCHMAN SEPTEMBER, Life TGOD THE GREEN ORGANIC DUTCHMAN SEPTEMBER, 2017 MAKING Life BETTER Disclaimer Forward-Looking Statement This documentation is a presentation (the Presentation ) of general background information about

More information

CORPORATE PRESENTATION CANADA S CANNABIS COMPANY

CORPORATE PRESENTATION CANADA S CANNABIS COMPANY CORPORATE PRESENTATION CANADA S CANNABIS COMPANY LEGAL DISCLAIMER NOTICE TO RECIPIENT This investment is suitable only for sophisticated investors for whom an investment does not constitute a complete

More information

Emerald Health Therapeutics Reports 1 st Quarter 2018 Financial Results and Provides Corporate Update

Emerald Health Therapeutics Reports 1 st Quarter 2018 Financial Results and Provides Corporate Update Emerald Health Therapeutics Reports 1 st Quarter 2018 Financial Results and Provides Corporate Update Commences commercial production at its Pure Sunfarms Delta 3 joint venture greenhouse operation VICTORIA,

More information

GLOBAL LEADER IN MEDICAL CANNABIS CREATED BY APHRIA AND NUUVERA COMBINATION

GLOBAL LEADER IN MEDICAL CANNABIS CREATED BY APHRIA AND NUUVERA COMBINATION GLOBAL LEADER IN MEDICAL CANNABIS CREATED BY APHRIA AND NUUVERA COMBINATION Combination capitalizes on Nuuvera s expansive international footprint, expanding network into Europe, Africa and the Middle

More information

PREMIUM MEDICAL CANNABIS POWERED BY SUNLIGHT

PREMIUM MEDICAL CANNABIS POWERED BY SUNLIGHT PREMIUM MEDICAL CANNABIS POWERED BY SUNLIGHT Q2 2018 Investor Presentation PREMIUM January MEDICAL CANNABIS 10, 2018 POWERED BY SUN DISCLAIMER This documentation is a presentation (the Presentation ) of

More information

VILLAGE FARMS INTERNATIONAL REPORTS YEAR END 2017 FINANCIAL RESULTS AND ANNOUNCES PLAN TO INCREASE PURE SUNFARMS 2019 PRODUCTION BY UP TO 30%

VILLAGE FARMS INTERNATIONAL REPORTS YEAR END 2017 FINANCIAL RESULTS AND ANNOUNCES PLAN TO INCREASE PURE SUNFARMS 2019 PRODUCTION BY UP TO 30% VILLAGE FARMS INTERNATIONAL REPORTS YEAR END 2017 FINANCIAL RESULTS AND ANNOUNCES PLAN TO INCREASE PURE SUNFARMS 2019 PRODUCTION BY UP TO 30% Pure Sunfarms to Pursue Accelerated Production Ramp Up Plan

More information

SUPREME PHARMACEUTICALS INC.

SUPREME PHARMACEUTICALS INC. SUPREME PHARMACEUTICALS INC. MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL RESULTS For the nine months ended March 31, 2016 Date: May 30, 2016 SUPREME PHARMACEUTICALS INC. Management Discussion and

More information

MORRO BAY RESOURCES LTD. PROVIDES FURTHER DETAILS ON THE PROPOSED REVERSE TAKEOVER TRANSACTION

MORRO BAY RESOURCES LTD. PROVIDES FURTHER DETAILS ON THE PROPOSED REVERSE TAKEOVER TRANSACTION MORRO BAY RESOURCES LTD. PROVIDES FURTHER DETAILS ON THE PROPOSED REVERSE TAKEOVER TRANSACTION June 7, 2017: Morro Bay Resources Ltd. ( Morro Bay or the Company ) (TSXV: MRB, OTCPink: MRRBF) is pleased

More information

DISCLAIMER STATEMENTS

DISCLAIMER STATEMENTS January 2019 DISCLAIMER STATEMENTS This presentation relates to an entity that is directly involved in the United States cannabis industry insofar as its business activities include the cultivation, production,

More information

The Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings Ltd. The Green Organic Dutchman Holdings Ltd. FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2018 AND 2017 1 to in this MD&A are expressed in thousands of Canadian dollars except where indicated otherwise.

More information

Aurora Cannabis and Liquor Stores N.A. Announce Investment to Develop Western Canadian Retail Cannabis Business

Aurora Cannabis and Liquor Stores N.A. Announce Investment to Develop Western Canadian Retail Cannabis Business February 5, 2018 TSX: ACB TSX: LIQ Aurora Cannabis and Liquor Stores N.A. Announce Investment to Develop Western Canadian Retail Cannabis Business Aurora to Acquire up to a 40% Equity Interest in Liquor

More information

Nurturing Shareholder Growth

Nurturing Shareholder Growth JULY 2018 Nurturing Shareholder Growth EMBLEM CORP. TSXV: EMC DISCLAIMER This documentation is a presentation (the Presentation ) of general background information about Emblem Corp s., ( Emblem ) activities

More information

Investor Presentation. TSX Venture (OGI) OTCQX Best Market (OGRMF)

Investor Presentation. TSX Venture (OGI) OTCQX Best Market (OGRMF) Investor Presentation TSX Venture (OGI) OTCQX Best Market (OGRMF) Disclaimer & Cautionary Statements This document is current as of February 8, 2019, except where otherwise stated. The information contained

More information

CORPORATE PRESENTATION

CORPORATE PRESENTATION CORPORATE PRESENTATION OCTOBER 2018 CSE: CHM OTCQB: CHMJF FORWARD LOOKING STATEMENTS This corporate document contains forward-looking statements and forward-looking information (collectively, forward-looking

More information

I n v e s t o r P r e s e n t a t i o n A c q u i s i t i o n o f C a n n a F a r m s

I n v e s t o r P r e s e n t a t i o n A c q u i s i t i o n o f C a n n a F a r m s I n v e s t o r P r e s e n t a t i o n A c q u i s i t i o n o f C a n n a F a r m s July 30, 2018 TSX-V: VIVO OTCQB: ABCCF Disclaimer Certain information included in this presentation, which was prepared

More information

DOJA Cannabis Company Limited (Formerly SG Spirit Gold Inc.)

DOJA Cannabis Company Limited (Formerly SG Spirit Gold Inc.) DOJA Cannabis Company Limited (Formerly SG Spirit Gold Inc.) Management s Discussion and Analysis For the three and six months ended September 30, 2017 Introduction This management s discussion and analysis

More information

THIS DOCUMENT MAY NOT BE DISTRIBUTED OR RELEASED IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES.

THIS DOCUMENT MAY NOT BE DISTRIBUTED OR RELEASED IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES. SecureCom Mobile Inc. CSE : SCE CSE : SCE.CN April 04, 2017 16:45 ET SecureCom Mobile and DFMMJ Investments Announce Definitive Agreement for Business Combination and Concurrent Financing With Strategic

More information

PREMIUM MEDICAL CANNABIS POWERED BY SUNLIGHT

PREMIUM MEDICAL CANNABIS POWERED BY SUNLIGHT PREMIUM MEDICAL CANNABIS POWERED BY SUNLIGHT Q2 2018 Investor Presentation PREMIUM January MEDICAL CANNABIS 10, 2018 POWERED BY SUN DISCLAIMER This documentation is a presentation (the Presentation ) of

More information

INVESTOR PRESENTATION. June 01, 2018 CSE: CALI OTCQB: FNNZF

INVESTOR PRESENTATION. June 01, 2018 CSE: CALI OTCQB: FNNZF INVESTOR PRESENTATION June 01, 2018 CSE: CALI OTCQB: FNNZF DISCLAIMER Cautionary Note Regarding Forward-Looking Information These materials include forward-looking statements. Such statements are based

More information

TSX:LEAF Investor Presentation March 2018

TSX:LEAF Investor Presentation March 2018 TSX:LEAF Investor Presentation March 2018 Price Close (Mar 16, 2018): $19.34 Market Capitalization: $1.9 billion Basic and F.D. Shares: 99.8/109.6 million Forward-Looking Information This Presentation

More information

CANNABIS WHEATON INCOME CORP. MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL RESULTS FOR THE PERIOD ENDED MARCH 31, Stated in Canadian Funds

CANNABIS WHEATON INCOME CORP. MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL RESULTS FOR THE PERIOD ENDED MARCH 31, Stated in Canadian Funds CANNABIS WHEATON INCOME CORP. MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL RESULTS FOR THE PERIOD ENDED MARCH 31, 2018 Stated in Canadian Funds DATE: MAY 30, 2018 For the Period Ended March 31, 2018

More information

FastForward Innovations Limited. ( FastForward ) Investee Company Update:

FastForward Innovations Limited. ( FastForward ) Investee Company Update: 29 January 2018 FastForward Innovations Limited ( FastForward ) Investee Company Update: GLOBAL LEADER IN MEDICAL CANNABIS CREATED BY PROPOSED APHRIA AND NUUVERA MERGER NUUVERA VALUED AT APPROXIMATELY

More information

ABcann Global Corporation. (formerly Panda Capital Inc.) Management s Discussion & Analysis

ABcann Global Corporation. (formerly Panda Capital Inc.) Management s Discussion & Analysis ABcann Global Corporation (formerly Panda Capital Inc.) Management s Discussion & Analysis For the Three and Six Months Ended June 30, 2017 Introduction This management s discussion and analysis ( MD&A

More information

Investor Presentation May September 2017

Investor Presentation May September 2017 Investor Presentation May 2018 September 2017 Forward Looking Statements 2 This presentation contains certain "forward looking statements". These statements relate to future events or future performance

More information

Q CONFERENCE CALL. Prepared remarks from: David L. Dunkel, Chairman and CEO Joseph J. Liberatore, President David M.

Q CONFERENCE CALL. Prepared remarks from: David L. Dunkel, Chairman and CEO Joseph J. Liberatore, President David M. Q4 2018 CONFERENCE CALL Prepared remarks from: David L. Dunkel, Chairman and CEO Joseph J. Liberatore, President David M. Kelly, CFO Disclaimer Certain of the statements contained herein, including earnings

More information

The Hydropothecary Corporation. Company Overview. Management Discussion & Analysis. For the three and nine months ending April 30, 2017 and 2016

The Hydropothecary Corporation. Company Overview. Management Discussion & Analysis. For the three and nine months ending April 30, 2017 and 2016 For the three and nine months ending April 30, 2017 and 2016 This management discussion and analysis ( MD&A ) of the financial condition and results of operations of The Hydropothecary Corporation and

More information

LOON ENERGY CORPORATION AGREES TO AMALGAMATION WITH EMERGING CANNABIS COMPANY

LOON ENERGY CORPORATION AGREES TO AMALGAMATION WITH EMERGING CANNABIS COMPANY LOON ENERGY CORPORATION AGREES TO AMALGAMATION WITH EMERGING CANNABIS COMPANY Calgary, Alberta: September 17, 2018 Loon Energy Corporation (NEX: LNE.H) ( Loon ) announces that it has entered into an Amalgamation

More information

Corporate Presentation March 2018

Corporate Presentation March 2018 Rapidly Creating a Global Cannabis Supplier Corporate Presentation March 2018 Disclaimer This presentation ( Presentation ) is provided on the basis that neither LGC Capital Ltd. ( LGC ) nor its officers,

More information

A Powerful Strategic Combination

A Powerful Strategic Combination A Powerful Strategic Combination Forward Looking Statements This Presentation (the Document ) by Aurora Cannabis Inc. ( Aurora or the Company ) has been compiled by management of the Company solely for

More information

TSX:LEAF Investor Presentation December 2017 Top Licensed Producer

TSX:LEAF Investor Presentation December 2017 Top Licensed Producer TSX:LEAF Investor Presentation December 2017 Top Licensed Producer Price Close (Dec 7, 2017): $15.47 Market Capitalization: $1.5 billion Basic and F.D. Shares: 94.1/101.4 million Forward-Looking Information

More information

DISCLAIMER STATEMENTS

DISCLAIMER STATEMENTS November 2018 DISCLAIMER STATEMENTS This presentation relates to an entity that is directly involved in the United States cannabis industry insofar as its business activities include the cultivation, production,

More information

VILLAGE FARMS INTERNATIONAL REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND ANNOUNCES COMMENCEMENT OF COMMERCIAL-SCALE GROWING AT DELTA 3 GREENHOUSE

VILLAGE FARMS INTERNATIONAL REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND ANNOUNCES COMMENCEMENT OF COMMERCIAL-SCALE GROWING AT DELTA 3 GREENHOUSE FOR IMMEDIATE RELEASE VILLAGE FARMS INTERNATIONAL REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND ANNOUNCES COMMENCEMENT OF COMMERCIAL-SCALE GROWING AT DELTA 3 GREENHOUSE NOT FOR DISTRIBUTION OVER UNITED

More information

EMERALD HEALTH THERAPEUTICS, INC. MANAGEMENT DISCUSSION AND ANALYSIS For the three and nine months ended September 30, 2017

EMERALD HEALTH THERAPEUTICS, INC. MANAGEMENT DISCUSSION AND ANALYSIS For the three and nine months ended September 30, 2017 EMERALD HEALTH THERAPEUTICS, INC. MANAGEMENT DISCUSSION AND ANALYSIS For the three and nine months ended September 30, 2017 Dated: November 15, 2017 - 2 - TABLE OF CONTENTS Forward-Looking Statements...

More information

TSX:LEAF Investor Presentation October 2017

TSX:LEAF Investor Presentation October 2017 TSX:LEAF Investor Presentation October 2017 Price Close (Oct 6, 2017): $9.80 Market Capitalization: $890 million Basic and F.D. Shares: 90.8/93.2 million Forward-Looking Information This Presentation contains

More information

Investor Presentation August 23, 2017

Investor Presentation August 23, 2017 Investor Presentation August 23, 2017 Forward-Looking Information This Presentation contains forward-looking information within the meaning of applicable Canadian securities legislation which are based

More information

Corporate Presentation November 2017

Corporate Presentation November 2017 Investing In High Yield Businesses Around The Globe Corporate Presentation November 2017 Disclaimer This presentation ( Presentation ) is provided on the basis that neither LGC Capital Ltd) (the Company

More information

EMERALD HEALTH THERAPEUTICS, INC.

EMERALD HEALTH THERAPEUTICS, INC. EMERALD HEALTH THERAPEUTICS, INC. MANAGEMENT DISCUSSION AND ANALYSIS For the three months ended March 31, 2018 Dated: May 28, 2018-1 - TABLE OF CONTENTS Forward-Looking Statements... 3 Overview... 5 Recent

More information

Liberty Health Sciences Inc. (formerly, SecureCom Mobile Inc.)

Liberty Health Sciences Inc. (formerly, SecureCom Mobile Inc.) CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS Liberty Health Sciences Inc. FOR THE THREE MONTHS ENDED MAY 31, 2018 (in Canadian Dollars) NOTICE TO READER Under National Instrument 51-102, Part 4,

More information

Zenabis November 21, 2018

Zenabis November 21, 2018 Zenabis November 21, 2018 Disclaimers IMPORTANT: YOU MUST READ THE FOLLOWING BEFORE CONTINUING. The information contained in this document has been prepared by Sun Pharm Investments Ltd. ( Sun Pharm or

More information

TSX-Venture Exchange: RRL

TSX-Venture Exchange: RRL SUGARBUD CRAFT GROWERS CORP. PROVIDES UPDATE REGARDING MANAGEMENT CHANGES AND ADDITIONS, FUNDING OF CANNABIS OPERATIONS, INSIDER PARTICIPATION IN RIGHTS OFFERING, INVESTMENT IN INNER SPIRIT HOLDINGS LTD.

More information

MANAGEMENT S DISCUSSION & ANALYSIS

MANAGEMENT S DISCUSSION & ANALYSIS MANAGEMENT S DISCUSSION & ANALYSIS This management discussion and analysis ( MD&A ) of the financial condition and results of operations of Aphria Inc., (the Company or Aphria ), is for the three and twelve

More information

Presented by: Eric Paul & Brad Rogers

Presented by: Eric Paul & Brad Rogers Improving the Quality of your Life Presented by: Eric Paul & Brad Rogers 1 A focused medical approach to meet the specific needs of the physicians and patients Standardized Products provide us the ability

More information

Highlights for Village Farms U.S. Hemp/CBD Initiative

Highlights for Village Farms U.S. Hemp/CBD Initiative Village Farms International Reports Fourth Quarter and Year End 2018 Financial Results Cannabis Joint Venture, Pure Sunfarms, Generates Positive Net Income in First Full Quarter of Sales and for the Full

More information

VILLAGE FARMS INTERNATIONAL REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS/PURE SUNFARMS EXPANDING CANNABIS PRODUCTION AND SALES

VILLAGE FARMS INTERNATIONAL REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS/PURE SUNFARMS EXPANDING CANNABIS PRODUCTION AND SALES FOR IMMEDIATE RELEASE VILLAGE FARMS INTERNATIONAL REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS/PURE SUNFARMS EXPANDING CANNABIS PRODUCTION AND SALES NOT FOR DISTRIBUTION OVER UNITED STATES WIRE SERVICES

More information

AURORA CANNABIS INC. MANAGEMENT S DISCUSSION AND ANALYSIS. For the three and six-month periods ended December 31, 2017

AURORA CANNABIS INC. MANAGEMENT S DISCUSSION AND ANALYSIS. For the three and six-month periods ended December 31, 2017 MANAGEMENT S DISCUSSION AND ANALYSIS For the three and six-month periods ended December 31, 2017 This Management s Discussion and Analysis ( MD&A ) reports on the consolidated financial condition and operating

More information

Cronos Group Inc. (formerly PharmaCan Capital Corp.) Management s Discussion & Analysis

Cronos Group Inc. (formerly PharmaCan Capital Corp.) Management s Discussion & Analysis Cronos Group Inc. (formerly PharmaCan Capital Corp.) Management s Discussion & Analysis For the Year Ended December 31, 2016 Introduction This Management Discussion and Analysis ( MD&A ) provides relevant

More information

POWERED BY SUNLIGHT 2016 ANNUAL REPORT

POWERED BY SUNLIGHT 2016 ANNUAL REPORT POWERED BY SUNLIGHT 2016 ANNUAL REPORT CONTENTS CHIEF EXECUTIVE OFFICER S MESSAGE 1 MANAGEMENT S DISCUSSION AND ANALYSIS 5 MANAGEMENT S RESPONSIBILITY FOR THE CONSOLIDATED FINANCIAL STATEMENTS 29 INDEPENDENT

More information

VILLAGE FARMS INTERNATIONAL REPORTS SECOND QUARTER 2017 FINANCIAL RESULTS

VILLAGE FARMS INTERNATIONAL REPORTS SECOND QUARTER 2017 FINANCIAL RESULTS VILLAGE FARMS INTERNATIONAL REPORTS SECOND QUARTER 2017 FINANCIAL RESULTS Second Quarter Highlighted by Transformational Venture that will see Diversification into Cannabis Production in Canada NOT FOR

More information

TIMIA Capital Presentation

TIMIA Capital Presentation TIMIA Capital Presentation TECHNOLOGY-ENABLED LENDING FOR GROWING SOFTWARE COMPANIES TSXV TCA Disclaimer Not an Offer to Purchase or Sell Securities This overview is for informational purposes and is not

More information

VILLAGE FARMS INTERNATIONAL REPORTS IMPROVED THIRD QUARTER 2017 FINANCIAL RESULTS AND PROVIDES CANNABIS JOINT VENTURE UPDATE

VILLAGE FARMS INTERNATIONAL REPORTS IMPROVED THIRD QUARTER 2017 FINANCIAL RESULTS AND PROVIDES CANNABIS JOINT VENTURE UPDATE VILLAGE FARMS INTERNATIONAL REPORTS IMPROVED THIRD QUARTER 2017 FINANCIAL RESULTS AND PROVIDES CANNABIS JOINT VENTURE UPDATE Third Quarter Highlighted by Submission of Application for Second Site Cannabis

More information

DISCLAIMER LIBERTY HEALTH SCIENCES INC. I INVESTORS PRESENTATION 2

DISCLAIMER LIBERTY HEALTH SCIENCES INC. I INVESTORS PRESENTATION 2 DISCLAIMER This documentation is a presentation (the Presentation ) of general background information about Liberty Health Sciences Inc. s ( Liberty Health Sciences ) activities current as of September

More information

CREATING A NORTH AMERICAN CANNABIS POWERHOUSE APRIL 2019

CREATING A NORTH AMERICAN CANNABIS POWERHOUSE APRIL 2019 CREATING A NORTH AMERICAN CANNABIS POWERHOUSE APRIL 2019 DISCLAIMER This presentation contains forward-looking information within the meaning of applicable Canadian securities legislation and may also

More information

GOODFOOD REPORTS STRONG FINANCIAL RESULTS WITH Q REVENUE GROWTH OF 164%, RECORD GROSS MARGINS AND POSITIVE CASH FLOW FROM OPERATIONS

GOODFOOD REPORTS STRONG FINANCIAL RESULTS WITH Q REVENUE GROWTH OF 164%, RECORD GROSS MARGINS AND POSITIVE CASH FLOW FROM OPERATIONS For Immediate Distribution GOODFOOD REPORTS STRONG FINANCIAL RESULTS WITH Q1 2019 REVENUE GROWTH OF 164%, RECORD GROSS MARGINS AND POSITIVE CASH FLOW FROM OPERATIONS Revenue for Q1 2019 was $29.6 million,

More information

Liberty Health Sciences Inc. (formerly, SecureCom Mobile Inc.)

Liberty Health Sciences Inc. (formerly, SecureCom Mobile Inc.) CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS Liberty Health Sciences Inc. FOR THE THREE AND SIX MONTHS ENDED AUGUST 31, 2018 (in Canadian Dollars) NOTICE TO READER Under National Instrument 51-102,

More information

CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) EMBLEM CORP. FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2018

CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) EMBLEM CORP. FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2018 CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) OF EMBLEM CORP. FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2018 NOTICE OF UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

More information

Golden Leaf Reports Fiscal First Quarter 2018 Results

Golden Leaf Reports Fiscal First Quarter 2018 Results Golden Leaf Reports Fiscal First Quarter 2018 Results Toronto, Ontario May 30, 2018 Golden Leaf Holdings Ltd. ( Golden Leaf or the Company ) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company

More information

Stone Ridge Exploration Corp. Suite Howe Street Vancouver, B.C. V6C 2C2

Stone Ridge Exploration Corp. Suite Howe Street Vancouver, B.C. V6C 2C2 NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES Stone Ridge Exploration

More information

DRIVING THE GLOBAL CANNABIS INDUSTRY. February 2019

DRIVING THE GLOBAL CANNABIS INDUSTRY. February 2019 DRIVING THE GLOBAL CANNABIS INDUSTRY February 2019 FORWARD-LOOKING STATEMENT This presentation contains forward-looking information within the meaning of applicable Canadian securities laws and forward-looking

More information

DRIVING THE GLOBAL CANNABIS INDUSTRY. February 2018

DRIVING THE GLOBAL CANNABIS INDUSTRY. February 2018 DRIVING THE GLOBAL CANNABIS INDUSTRY February 2018 FORWARD-LOOKING STATEMENT This presentation contains forward-looking information within the meaning of applicable Canadian securities laws and forward-looking

More information

FORM 7 MONTHLY PROGRESS REPORT

FORM 7 MONTHLY PROGRESS REPORT FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: Future Farm Technologies Inc. (the Issuer or Future Farm ). Trading Symbol: FFT Number of Outstanding Listed Securities: 100,223,612 Date: December

More information

Investor Presentation March September 2017

Investor Presentation March September 2017 Investor Presentation March 2018 September 2017 Forward Looking Statements 2 This presentation contains certain "forward looking statements". These statements relate to future events or future performance

More information

CRONOS GROUP INC. CONSOLIDATED FINANCIAL STATEMENTS

CRONOS GROUP INC. CONSOLIDATED FINANCIAL STATEMENTS CRONOS GROUP INC. CONSOLIDATED FINANCIAL STATEMENTS For the Years Ended December 31, 2017 and December 31, 2016 (Expressed in Canadian dollars) Cronos Group Inc. Consolidated Financial Statements For the

More information

Corporate Presentation

Corporate Presentation Corporate Presentation March 2018 CSE: CRZ OTCQX: CNNRF 0 INVESTOR PRESENTATION STOCK DISCLAIMERS Forward Looking Information This investor presentation dated March 2018 (the Presentation ) contains forward-looking

More information

Cronos Group Inc. (formerly PharmaCan Capital Corp.) Management s Discussion & Analysis

Cronos Group Inc. (formerly PharmaCan Capital Corp.) Management s Discussion & Analysis Cronos Group Inc. (formerly PharmaCan Capital Corp.) Management s Discussion & Analysis For the Three Month Periods Ended March 31, 2017 and March 31, 2016 Introduction This Management Discussion and Analysis

More information

Investor Presentation February September 2017

Investor Presentation February September 2017 Investor Presentation February 2018 September 2017 Forward looking statements 2 This presentation contains certain "forward looking statements". These statements relate to future events or future performance

More information

Blockchain. Delivered.

Blockchain. Delivered. CSE: BLK Blockchain. Delivered. Management Presentation Q1 2018 2018 BLOK Technologies Inc. Disclaimer Except for the statements of historical fact, this presentation contains forward-looking information

More information

POCML 4 INC. Management s Discussion and Analysis. (a Capital Pool Corporation) For the Quarter Ended: March 31, Date of Report: May 30, 2018

POCML 4 INC. Management s Discussion and Analysis. (a Capital Pool Corporation) For the Quarter Ended: March 31, Date of Report: May 30, 2018 POCML 4 INC. (a Capital Pool Corporation) Management s Discussion and Analysis For the Quarter Ended: March 31, 2018 Date of Report: May 30, 2018 This management s discussion and analysis of the financial

More information

EMBLEM CORP. MANAGEMENT S DISCUSSION AND ANALYSIS For the year ended December 31, 2016

EMBLEM CORP. MANAGEMENT S DISCUSSION AND ANALYSIS For the year ended December 31, 2016 MANAGEMENT S DISCUSSION AND ANALYSIS CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This Management s Discussion and Analysis [ MD&A ] of Emblem Corp. [ Emblem or the Company ] contains forward-looking

More information

BLISSCO CANNABIS CORP. MANAGEMENT DISCUSSION AND ANALYSIS Nine Months Ended October 31, 2018

BLISSCO CANNABIS CORP. MANAGEMENT DISCUSSION AND ANALYSIS Nine Months Ended October 31, 2018 MANAGEMENT DISCUSSION AND ANALYSIS Nine Months Ended 1.1 Date This Management Discussion and Analysis ( MD&A ) of BlissCo Cannabis Corp. (the Company or BlissCo ) has been prepared by management as of

More information

MAPLE LEAF GREEN WORLD INC. THREE MONTHS ENDED MARCH 31, 2017 MANAGEMENT S DISCUSSION AND ANALYSIS

MAPLE LEAF GREEN WORLD INC. THREE MONTHS ENDED MARCH 31, 2017 MANAGEMENT S DISCUSSION AND ANALYSIS 1.1 Date and Introduction This Management's Discussion and Analysis ("MD&A") is intended to help the reader understand the financial statements of Maple Leaf Green World Inc., referred to as Maple Leaf

More information

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED PREPARED BY MANAGEMENT) (EXPRESSED IN CANADIAN DOLLARS) THREE MONTH PERIOD ENDED FEBRUARY 28, 2018 (formerly Genovation Capital Corp.) NOTICE

More information

Consolidated Financial Statements of

Consolidated Financial Statements of Consolidated Financial Statements of 48North Cannabis Corp. June 30, 2018 and 2017 1 Independent Auditors Report To the Shareholders of 48North Cannabis Corp.: We have audited the accompanying consolidated

More information

WEEDMD INC. (Formerly Aumento Capital V Corporation)

WEEDMD INC. (Formerly Aumento Capital V Corporation) CONSOLIDATED FINANCIAL STATEMENTS WEEDMD INC. December 31, 2017 and 2016 (Expressed in Canadian Dollars) CONSOLIDATED FINANCIAL STATEMENTS For the Years Ended December 31, 2017 and 2016 CONTENTS Page Auditor

More information

Corporate Presentation

Corporate Presentation Corporate Presentation April 2018 CSE: CRZ OTCQX: CNNRF INVESTOR PRESENTATION STOCK DISCLAIMERS Forward Looking Information This investor presentation dated March 2018 (the Presentation ) contains forward-looking

More information

For personal use only

For personal use only 12 December 2017 MMJ Expands Canadian Cannabis Footprint via Strategic Investment in Late-Stage ACMPR Applicant Weed Me Inc. Weed Me is a late stage ACMPR applicant based in Canada s most populated province,

More information

THE FUTURE IS ORGANIC INDUSTRY LEADER IN LOW-COST, CERTIFIED ORGANIC CANNABIS PRODUCTION

THE FUTURE IS ORGANIC INDUSTRY LEADER IN LOW-COST, CERTIFIED ORGANIC CANNABIS PRODUCTION THE FUTURE IS ORGANIC INDUSTRY LEADER IN LOW-COST, CERTIFIED ORGANIC CANNABIS PRODUCTION August 2018 Disclaimer This presentation is not, and under no circumstances is to be construed as, a prospectus,

More information

VIVO CANNABIS INC. (formerly ABcann Global Corporation) Management s Discussion & Analysis. For the Three and Six Months Ended June 30, 2018

VIVO CANNABIS INC. (formerly ABcann Global Corporation) Management s Discussion & Analysis. For the Three and Six Months Ended June 30, 2018 VIVO CANNABIS INC. (formerly ABcann Global Corporation) Management s Discussion & Analysis For the Three and Six Months Ended June 30, 2018 August 29, 2018 Introduction This management s discussion and

More information

Harvest One Cannabis Inc.

Harvest One Cannabis Inc. Condensed Combined Consolidated Interim Financial Statements of Harvest One Cannabis Inc. For the three months ended September 30, 2017 and 2016 Table of contents Condensed combined consolidated interim

More information

CANOPY GROWTH CORPORATION

CANOPY GROWTH CORPORATION CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (IN CANADIAN DOLLARS) TABLE OF CONTENTS Condensed interim consolidated statements of financial position... 1 Condensed interim consolidated

More information

DRIVING THE GLOBAL CANNABIS INDUSTRY. Bruce Linton Founder, Chairman & Co-CEO November 2018

DRIVING THE GLOBAL CANNABIS INDUSTRY. Bruce Linton Founder, Chairman & Co-CEO November 2018 DRIVING THE GLOBAL CANNABIS INDUSTRY Bruce Linton Founder, Chairman & Co-CEO November 2018 FORWARD-LOOKING STATEMENT This presentation contains forward-looking information within the meaning of applicable

More information

STRATEGIC PARTNERSHIP WITH ALTRIA TO ACCELERATE GROWTH AND INNOVATION

STRATEGIC PARTNERSHIP WITH ALTRIA TO ACCELERATE GROWTH AND INNOVATION NASDAQ / TSX TICKER CRON STRATEGIC PARTNERSHIP WITH ALTRIA TO ACCELERATE GROWTH AND INNOVATION December 2018 Disclaimers & Cautionary Statements C R O N O S G R O U P INC. This communication contains forward-looking

More information

CSE FORM 2A LISTING STATEMENT

CSE FORM 2A LISTING STATEMENT TERRASCEND CORP. CSE FORM 2A LISTING STATEMENT APRIL 26, 2017 TABLE OF CONTENTS 1. GLOSSARY... 3 2. CORPORATE STRUCTURE... 4 3. GENERAL DEVELOPMENT OF THE BUSINESS... 5 4. NARRATIVE DESCRIPTION OF THE

More information

GoviEx and Denison to combine African uranium assets

GoviEx and Denison to combine African uranium assets NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA March 30, 2016 GoviEx and Denison to combine African uranium assets TORONTO, ONTARIO GoviEx Uranium Inc. (CSE: GXU) ( GoviEx ) and Denison Mines Corp.

More information

Condensed Interim Consolidated Financial Statements

Condensed Interim Consolidated Financial Statements Condensed Interim Consolidated Financial Statements (Expressed in Canadian Dollars) CONDENSED INTERIM CONSOLIDATED STATEMENTS OF FINANCIAL POSITION ASSETS June 30 December 31 2018 2017 Current Cash and

More information

Medical Marijuana A Growing Business

Medical Marijuana A Growing Business TSXV:TPI November 2014 Medical Marijuana A Growing Business Forward Looking Statements Certain statements in this corporate presentation constitute forward-looking statements, within the meaning of applicable

More information

TETRA BIO-PHARMA INC. CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

TETRA BIO-PHARMA INC. CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS TETRA BIO-PHARMA INC. CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS Three and six months ended August 31, 2017 Management's Responsibility for the condensed consolidated interim financial statements

More information

TSX VENTURE EXCHANGE SHORT FORM OFFERING DOCUMENT. SABER CAPITAL CORP. (the Issuer or Saber ) 67 East 5th Avenue Vancouver, British Columbia V5T 1G7

TSX VENTURE EXCHANGE SHORT FORM OFFERING DOCUMENT. SABER CAPITAL CORP. (the Issuer or Saber ) 67 East 5th Avenue Vancouver, British Columbia V5T 1G7 The securities offered hereunder are speculative in nature. Information concerning the risks involved may be obtained by reference to this document; further clarification, if required, may be sought from

More information

DRIVING THE GLOBAL CANNABIS INDUSTRY. Bruce Linton Chairman, Founder & Co-CEO February 2019

DRIVING THE GLOBAL CANNABIS INDUSTRY. Bruce Linton Chairman, Founder & Co-CEO February 2019 DRIVING THE GLOBAL CANNABIS INDUSTRY Bruce Linton Chairman, Founder & Co-CEO February 2019 FORWARD-LOOKING STATEMENT This presentation contains forward-looking information within the meaning of applicable

More information

SUPREME PHARMACEUTICALS INC.

SUPREME PHARMACEUTICALS INC. SUPREME PHARMACEUTICALS INC. MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL RESULTS For the six months ended December 31, 2016 Date: March 1, 2017 SUPREME PHARMACEUTICALS INC. Management Discussion

More information

Liberty Health Sciences Inc. (formerly, SecureCom Mobile Inc.)

Liberty Health Sciences Inc. (formerly, SecureCom Mobile Inc.) CONSOLIDATED ANNUAL FINANCIAL STATEMENTS Liberty Health Sciences Inc. FOR THE PERIOD ENDED FEBRUARY 28, 2018 (in Canadian Dollars) Table of contents Consolidated Statements of Financial Position... 1 Consolidated

More information

THERATECHNOLOGIES ANNOUNCES FINANCIAL RESULTS FOR FISCAL YEAR 2017

THERATECHNOLOGIES ANNOUNCES FINANCIAL RESULTS FOR FISCAL YEAR 2017 THERATECHNOLOGIES ANNOUNCES FINANCIAL RESULTS FOR FISCAL YEAR 2017 Montreal, Canada February 7, 2018 Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the year

More information

SECURITIES AND EXCHANGE COMMISSION. Washington, D.C FORM 8-K CURRENT REPORT

SECURITIES AND EXCHANGE COMMISSION. Washington, D.C FORM 8-K CURRENT REPORT SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):

More information

Trailing PE Forward PE Buy 10 Analysts. 1-Year Return: -5.1% 5-Year Return: 3328%

Trailing PE Forward PE Buy 10 Analysts. 1-Year Return: -5.1% 5-Year Return: 3328% Last Close 13.71 (CAD) Avg Daily Vol 9.0M 52-Week High 22.00 Trailing PE 41.6 Annual Div -- ROE 7.7% LTG Forecast -- 1-Mo 38.2% 2019 February 21 TORONTO Exchange Market Cap 3.2B 52-Week Low 4.76 Forward

More information

EMERALD HEALTH THERAPEUTICS, INC. (Formerly T-Bird Pharma Inc.) MANAGEMENT DISCUSSION AND ANALYSIS For the three and six months ended June 30, 2016

EMERALD HEALTH THERAPEUTICS, INC. (Formerly T-Bird Pharma Inc.) MANAGEMENT DISCUSSION AND ANALYSIS For the three and six months ended June 30, 2016 EMERALD HEALTH THERAPEUTICS, INC. MANAGEMENT DISCUSSION AND ANALYSIS Dated: August 22, 2016 Forward-Looking Statements... 2 Overview... 3 Recent Developments and Events after the Reporting Period... 4

More information

EMERALD HEALTH THERAPEUTICS, INC. MANAGEMENT DISCUSSION AND ANALYSIS For the three months ended March 31, 2017

EMERALD HEALTH THERAPEUTICS, INC. MANAGEMENT DISCUSSION AND ANALYSIS For the three months ended March 31, 2017 EMERALD HEALTH THERAPEUTICS, INC. MANAGEMENT DISCUSSION AND ANALYSIS For the three months ended March 31, 2017 Dated: May 25, 2017 - 2 - TABLE OF CONTENTS Forward-Looking Statements... 3 Overview... 4

More information

Corporate Presentation

Corporate Presentation Corporate Presentation APRIL 2018 OTCQB: AGTK 1 INVESTOR PRESENTATION STOCK DISCLAIMERS Forward Looking Information This investor presentation dated April 2018 (the Presentation ) contains forward-looking

More information

FORM 7 MONTHLY PROGRESS REPORT

FORM 7 MONTHLY PROGRESS REPORT FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: MARAPHARM VENTURES INC. (Marapharm or the Company ) (the Issuer ). Trading Symbol: MDM Number of Outstanding Listed Securities: 136,187,202 Date: July

More information

CORPORATE PRESENTATION JULY 2018

CORPORATE PRESENTATION JULY 2018 CORPORATE PRESENTATION JULY 2018 DISCLAIMER THIS MANAGEMENT PRESENTATION (THE "PRESENTATION") WAS PREPARED AS A SUMMARY OVERVIEW ONLY OF THE CURRENT AFFAIRS OF ECOBALT SOLUTIONS INC. FOMERLY FORMATION

More information

The Hydropothecary Corporation

The Hydropothecary Corporation For the three months ended October 31, 2017 and 2016 This management discussion and analysis ( MD&A ) of the financial condition and results of operations of The Hydropothecary Corporation and its wholly-owned

More information

C O R P O R A T E P R E S E N T A T I O N APRIL 2018 C$ RQB

C O R P O R A T E P R E S E N T A T I O N APRIL 2018 C$ RQB C O R P O R A T E P R E S E N T A T I O N APRIL 2018 C$ RQB U$ RVVQF 1IT F O R W A R D L O O K I N G S T A T E M E N T This presentation contains forward-looking statements. These forward-looking statements

More information